eg: UK or Brides UK or Classical Art or Buy Music or Spirituality
 
eg: UK or Brides UK or Classical Art or Buy Music or Spirituality
 

Your Online Guide » Common Illness » Stem Cell Research Pros and Cons

[P781]Pros And Cons Of Stem Cell Research
by Brady Quist, Bra

Many of us know that the center of the debate of the Pros and Cons of Stem Cell Research revolves around embryonic stem cells and whether or not using them is morally appropriate. But, are politics and the media hiding the real potential of it's brother Adult Stem Cell Research? Ultimately, the real question is whether or not Adult Stem Cells have as many capabilities as Embryonic Stem Cells. For many years the stem cell debate was fueled by the embryonic stem cell advocates saying that Adult Stem Cells weren't really capable of turning into other types of cells (which is the real benefit of stem cell research) and were therefore limited in what they could become. You might be surprised at the new developments in Adult Stem Cell Research.

It should be noted that more money is given to Adult Stem Cell Research (the NIH gave $190 Million last year compared to the $24.8 million given for Embryonic Stem Cells). We hear all the time, from advocates such as Michael J. Fox, that Embryonic Stem Cells are the real future in stem cell research and that the promising research is done in the field. But, what many of the Adult Stem Cell critics are missing is that Adult Stem Cells have been used in many treatments 72 adult stem cell treatments have been performed at last count, while a whopping 0 have been performed from Embryonic Stem Cells. These same Adult stem cells are used in bone-marrow transplants and even treat certain cases of leukemia and other blood disorders. There are also treatments being made for heart attacks, liver, bone and brain diseases and disorders. Adult Stem Cells can also be derived from many places such as Umbilical Cord Blood, Hair Follicles, Skin Cells, and several others.

“Osiris, which grew out of research by scientists at Case Western University in Cleveland, is using stem cells from bone-marrow donors to target, among other maladies, heart disease, specifically heart attacks. It is in early-stage human testing of a therapy in which heart-attack patients are intravenously injected with stem cells that are said to migrate to the heart and replace damaged cells.” - The Washington Post
John Hopkins University Professor, Saul J. Sharkis, who has mad advances in Adult Stem Cell Research, was very surprised at what has been accomplished in Adult Stem Cell Research. He says, “It is mind-blowing stuff,” and “I never would have thought this would be possible … Preposterous. Not Possible. No Way.”

Obviously many in the scientific community are excited and surprised by these findings. If this really is the answer, it could be the end to the debate over the Pros and Cons of Stem Cell Research as we know it. It is definitely an exciting possibility that has already yielded some great successes.


Typically when you think of trading stocks, the major stock exchanges may come to mind like the New York Stock Exchange (NYSE), the National Association of Securities Dealers Automated Quotations (NASDAQ), and the American Stock Exchange (AMEX). A Penny stock is a low priced security for a very small company with a market capitalization of under $500 million and usually trade in very low volumes. Penny stocks also trade on other "other the counter" exchanges like the OTCBB and Pink Sheets.

Due to the low trading volumes, penny stocks are an investment option that comes with a sizeable amount of risk. According the Securities and Exchange Commission, potential investors in penny stocks should be aware of the fact that due to the low trading volume of these stocks, it is possible that an investor won't find a buyer for their shares. Finding accurate price quotations are also difficult making it a strong possibility that an investor can lose their entire investment.

Penny stocks do carry a certain appeal for many different kinds of investors. Chances are though, a new investor looking for a potentially lucrative investments with a fairly low entry price will run across the penny stock. The allure comes in the fact that at such low prices any changes are often measurable in hundreds of percent in a given day or two. An investor's stock value can literally become worth double or even triple the original investment amount.

Conversely, the price of a penny stock can drop in value just as quickly. New and inexperienced investors would do well to avoid making penny stocks a major part of their investment portfolio. Also due to the low listing requirements on exchanges like OCTBB and Pink Sheets, many companies are not to be considered safe investments. Many of the companies listed on alternative exchanges lack enough financial history to be able to accurately determine if they would make a good investment or not. In some cases, companies that are considered to be penny stocks are either new companies or are in some cases dangerously close to bankruptcy.

Unfortunately, some traders have even taken to artificially manipulating stock prices by buying up large amounts of a stock and then convincing individual investors of the need to buy. Since most of these stocks aren't in such great demand, an investor will have to lower his asking price in order to entice a bidder, oftentimes at a loss.

Not every company that trades for "pennies" should be considered fraudulent. Some are simply small companies trying to grow their business and are working very hard to end up on the larger market exchanges. Wading through the fraudulent companies to find the truly reputable companies capable of helping an investor turn a large profit may not be worth it. Investors with low investment income may be convinced that just one good trade can triple their investment, but in the end an investor is better off choosing an investment from a company that they have researched and are convinced that this company's value will grow in the future.
Article Source : Stem Cell Research Pros and Cons

About Author
Both Brady Quist & Mika Hamilton are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.

Brady Quist has sinced written about articles on various topics from E Books, Computers and The Internet and Stem Cell. Brady Quist's blog discusses. Brady Quist's top article generates over 5400 views. to your Favourites.

Mika Hamilton has sinced written about articles on various topics from Investments, Banking and Bear Stock Market. More Articles & Tutorials and a Free E-Course at. Mika Hamilton's top article generates over 90500 views. to your Favourites.
EditorialToday Common Illness has 2 sub sections. Such as Other Conditions and Medical Conditions. With over 20,000 authors and writers, we are a well known online resource and editorial services site in United Kingdom, Canada & America . Here, we cover all the major topics from self help guide to A Guide to Business, Guide to Finance, Ideas for Marketing, Legal Guide, Lettre De Motivation, Guide to Insurance, Guide to Health, Guide to Medical, Military Service, Guide to Women, Pet Guide, Politics and Policy , Guide to Technology, The Travel Guide, Information on Cars, Entertainment Guide, Family Guide to, Hobbies and Interests, Quality Home Improvement, Arts & Humanities and many more.
About Editorial Today | Contact Us | Terms of Use | Submit an Article | Our Authors